Effectiveness of Improving Diagnostic and Communication Skills on Antibiotic Prescribing Appropriateness in Acute Cough

Respiratory Tract Infections Clinical Trial

— ISAAC-CAT  

Official title:

Effectiveness and Cost-effectiveness of Improving Clinicians' Diagnostic and Communication Skills on Antibiotic Prescribing Appropriateness in Patients With Acute Cough in Primary Care in Catalonia.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03931577
• Other study ID #: P18/227
• Status: Not yet recruiting
• Phase: N/A
• Start date: November 1, 2019
• Est. completion date: December 31, 2021

Study information

• Verified date: April 2019
• Source: Jordi Gol i Gurina Foundation
• Contact: Ana Moragas, MD PhD
• Phone: 0034600072170
• Email: anamaria.moragas[@]urv.cat
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Despite their marginal benefit, about 60% of uncomplicated acute lower respiratory infections (ALRTI) are currently treated with antibiotics. Several strategies have been developed to reduce inappropriate antibiotic prescribing, with the use of point-of-care C-reactive protein (CRP) testing and the improvement of the communication skills being the most effective interventions, but most of the studies have been carried out outside Mediterranean countries. This study is aimed at evaluating the effect of a disease-focused intervention (CRP) and an illness-focused intervention (improvement of communication skills to optimise doctor-patient consultations and share-decision making with the aid of patient-centred leaflets) on antibiotic prescribing for patients with ALRTIs in Catalan primary care by means of a cluster, randomised, factorial, controlled trial. Primary care centres will be assigned to four trial arms: usual care, use of CRP testing, enhanced communication skills backed up with leaflets, or combined interventions. The main outcome will be antibiotic use within the first 6 weeks and the quality adjusted life years. A pharmacoeconomic analysis of the impact of these interventions will be assessed.

Description:

Background: Most antibiotics are prescribed in primary care, and most commonly for acute lower respiratory infections (ALRTI). Despite their marginal benefit, about 60% of these infections are currently treated with antibiotics in Catalonia, Spain. Several strategies have been developed to reduce inappropriate antibiotic prescribing, with the use of C-reactive protein (CRP) rapid testing and the improvement of the communication skills being the most effective interventions. However, most studies have been carried out outside Mediterranean countries. This study aims to evaluate the effectiveness and the efficiency of a continuous disease-focused intervention (CRP) and an illness-focused intervention (enhancement of communication skills to optimise doctor-patient consultations and share decision making with the aid of patient-centred leaflets) on antibiotic prescribing in patients with ALRTIs in Catalan primary care centres.

Methods/design: A cluster, randomised, factorial, controlled trial aimed at including 20 primary care centres (n=2,940 patients) with patients older than 18 years presenting for a first consultation with ALRTI, therefore with presence of infected acute cough of up to 3 weeks' duration as the predominant symptom. Centres, according to socioeconomic and antibiotic consumption, will be randomly assigned according to hierarchical clustering to any of four trial arms: usual care, CRP testing, enhanced communication skills backed up with patient leaflets, or combined interventions. A cost-effectiveness and cost-utility analysis will be performed from the perspective of public health system. A qualitative study aimed at identifying the expectations and concerns in patients with ALRTIs and the satisfaction of clinicians with the different interventions will also be performed. Clinicians assigned to the interventions will participate in a 2-hour training workshop before the inception of the trial and will receive a monthly intervention-tailored training module during the trial. Clinical effectiveness will be measured by the antibiotic use within the first 6 weeks and the quality adjusted life years and secondary outcomes will be duration of illness and severity of cough measured with a symptom diary, healthcare reconsultations, hospital admissions and complications. National health care perspective will be adopted and the temporal horizon of the analysis will be one year. Health care costs will be considered and expressed in € of the current year of the analysis. Univariate and multivariate sensitivity analysis will be carried out.

Discussion: The ISAAC-CAT project aims to improve the management of ALRTIs in primary care through use of two different clinicians' skills to help target antibiotic prescribing only to those most likely to benefit, and thereby reduce the risk of unnecessary exposure to antibiotics leading to adverse effects and/or the development of AMR without having a negative impact on health status, thus benefiting individual patients and society at large. This project will contribute to evaluate the effectiveness and efficiency of different strategies for more appropriate antibiotic prescribing that are currently out of the scope of the actual guidelines.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 2940
• Est. completion date: December 31, 2021
• Est. primary completion date: February 28, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age equal or older than 18 years

• first consultation for acute cough (new cough or worsening of a previous cough) as the predominant symptom

• of up to 3 weeks' duration

• which the clinician believes to be an infectious acute lower respiratory tract infection

Exclusion Criteria:

• a working diagnosis of a non-infective disorder, such as heart failure, pulmonary embolus, oesophageal reflux, or allergy

• use of antibiotics in the previous two weeks

• immunological deficiencies, and/or

• inability to provide informed consent or unable to follow the study procedures

Related Conditions & MeSH terms

• Cough
• Respiratory Tract Infections

Intervention

Diagnostic Test:
• C-reactive protein rapid testing
Continuous (workshop and monthly web-based training) disease-focused intervention with the provision of CRP rapid testing in the primary care practices.

Procedure:
• Communication skill enhancement
Continuous (on-site and monthly online training) illness-focused intervention (enhancement of communication skills to optimise doctor-patient consultations and share decision making with the aid of patient-centred leaflets) in the primary care practices.

Locations

Country	Name	City	State
Spain	La Marina Health Center	Barcelona	Catalonia

Sponsors (4)

Lead Sponsor	Collaborator
Jordi Gol i Gurina Foundation	Fundacio d'Atencio Primaria, Universitat Internacional de Catalunya, Universitat Pompeu Fabra

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Antibiotic use	Number of antibiotics consumed (as documented in the CRFs and double-checked by the Pharmacy Unit of Institut Català de Salut that can track if the antibiotic has been dispensed at any of the Catalan pharmacies)	Day 42
Primary	Health status	Quality of life score obtained using the EuroQol questionnaire	Difference between baseline visit and day 42
Secondary	Re-consultations and complications	Number of re-consultation for new or worsening symptoms, new signs, or hospital admission, assessed by review of medical notes (practice staff, the local study team, or both using a standard form to report these data), and Number of complications regarding the ALRTI	Day 42
Secondary	Duration of symptoms and duration of severe symptoms	Number of days until symptoms are rated daily as 0 (no problem) (information is reported by patients in self-completed diaries)	Day 42
Secondary	Antibiotic prescription at the baseline visit	Number of antibiotic prescriptions at the baseline visit, differentiating immediate and delayed antibiotic prescribing, and antibiotic dispensing at the pharmacies	Baseline visit
Secondary	Drugs other than antibiotics	Number of non-antibiotic prescriptions (reported by patients in self-completed diaries)	Day 42
Secondary	Tests ordered by clinicians	Number of tests ordered by clinicians (reported in the CRF)	Day 42
Secondary	Patient satisfaction with care	Patient satisfaction score reported in the symptom diary. Measured with a question that has used in previous studies: How satisfied are you with the consultation? Range from 0 (nothing satisfied) to 5 (extremely satisfied).	Day 14
Secondary	Patient perception of the usefulness of the information received.	Patient perception score about the usefulness of the information received. Measured with a question that has used in previous studies: Do you consider that the information received from your doctor has been useful? Range from 0 (nothing useful) to 5 (extremely useful).	Day 14
Secondary	Patient future consulting intention	Patient future consulting intention score. Measured with a question that has used in previous studies: Do you think you will attend the doctor in future occasions in case you present the same symptoms? Range from 0 (totally unlikely) to 5 (sure).	Day 14
Secondary	Serious adverse events	Number of serious adverse events (assessed by review of medical notes (practice staff, the local study team, or both using a standard form to report these data)	Day 42
Secondary	Absenteeism	Number of days of sick leave (collected in the CRFs)	Baseline visit